                         SEQUENCE LISTING

<110>  Dicerna Pharmaceuticals, Inc.
       Brown, Bob Dale
       Ying, Bo
 
<120>  PROCESS FOR FORMULATING AN ANIONIC AGENT

<130>  3904/1123WO

<150>  61/784,810
<151>  2013-03-14

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  25
<212>  DNA
<213>  artificial

<220>
<223>  synthetic oligonucleotide

<400>  1
gccagacuuu guuggauuug aaatt                                             25


<210>  2
<211>  27
<212>  DNA
<213>  artificial

<220>
<223>  synthetic oligonucleotide

<400>  2
aauuucaaau ccaacaaagu cuggcuu                                           27


<210>  3
<211>  25
<212>  DNA
<213>  artificial

<220>
<223>  synthetic oligonucleotide

<400>  3
aggaacuaug accucgacua cgact                                             25


<210>  4
<211>  27
<212>  DNA
<213>  artificial

<220>
<223>  synthetic oligonucleotide

<400>  4
agucguaguc gaggucauag uuccugu                                           27


<210>  5
<211>  25
<212>  DNA
<213>  artificial

<220>
<223>  synthetic oligonucleotide

<400>  5
agcuuuuuug cccugcguga ccaga                                             25


<210>  6
<211>  27
<212>  DNA
<213>  artificial

<220>
<223>  synthetic oligonucleotide

<400>  6
ucuggucacg cagggcaaaa aagcucc                                           27


<210>  7
<211>  25
<212>  DNA
<213>  artificial

<220>
<223>  synthetic oligonucleotide

<400>  7
auauuuuccc aucuguauua uuutt                                             25


<210>  8
<211>  27
<212>  DNA
<213>  artificial

<220>
<223>  synthetic oligonucleotide

<400>  8
guuauaaaag gguagacaua auaaaaa                                           27


